- •Data Collection of Primary
- •Portions of this presentation are based on
- •Part I
- •Rationale for Non-malignant CNS
- •History 1992 -1996
- •History 1998
- •BTWG Recommendations (1)
- •BTWG Recommendations (2)
- •BTWG Recommendations (3)
- •History 2000
- •History 2001-2002
- •Reportable Brain-Related Tumors
- •Reportable Brain-Related Tumors
- •Reportable Brain-Related Tumors
- •Reportable Brain-Related Tumors
- •Reportable Brain-Related Tumors
- •Reportable Brain-Related Tumors
- •History 2003
- •Impact of Collecting Data on Non-malignant CNS Tumors (1)
- •Impact of Collecting Data on Non-malignant CNS Tumors (2)
- •Impact of Collecting Data on Non-malignant CNS Tumors (3)
- •Impact of Collecting Data on Non-malignant CNS Tumors (4)
- •Case-finding (1)
- •Case-finding (2)
- •Case-finding Sources
- •ICD-9-CM Codes for Case- finding
- •Unusual and Ambiguous
- •Part II
- •CNS Functional Anatomy
- •CNS Anatomy
- •Intracranial Sites
- •Cerebrum
- •Cerebellum and Brain Stem
- •The Ventricular System
- •Pineal and Pituitary Glands
- •Cranial Nerves
- •Meninges
- •Tentorium
- •Spinal Cord
- •Cellular Classification
- •Glial Tumors (1)
- •Glial Tumors (2)
- •Glial Tumors (3)
- •Glial Tumors (4)
- •Non-Glial Tumors (1)
- •Non-Glial Tumors (2)
- •Other CNS Tumors (1)
- •Other CNS Tumors (2)
- •Other CNS Tumors (3)
- •Other CNS Tumors (4)
- •Childhood versus Adult
- •Childhood Brain Tumors
- •Cellular Classification
- •Cellular Classification
- •Cellular Classification
- •ICD-O-3 Coding Issues (1)
- •ICD-O-3 Coding Issues (2)
- •Grade for CNS Tumors
- •WHO Grade (1)
- •WHO Grade (2)
- •Kernohan Grade
- •St. Anne-Mayo Grade (1)
- •St. Anne-Mayo Grade (2)
- •Grade for CNS Tumors
- •Part III
- •Determining Multiple
- •Coding Laterality (1)
- •Coding Laterality (2)
- •Determining Multiple
- •Determining Multiple
- •Determining Multiple
- •Determining Multiple
- •Determining Multiple
- •Determining Multiple
- •Determining Multiple
- •Determining Multiple
- •Determining Multiple
- •Determining Multiple
- •Determining Multiple
- •Determining Multiple
- •Determining Multiple
- •General Rules for Determining Multiple Primaries of CNS Sites
- •General Rules for Determining
- •General Rules for Determining
- •Histologic Transformation (1)
- •Histologic Transformation (2)
- •Histologic Transformation (3)
- •Histologic Transformation (4)
- •Histologic Transformation (5)
- •Coding Sequence Numbers
- •Coding Sequence Numbers
- •Coding Sequence Numbers
- •Assigning Diagnosis Date
- •Part IV
- •Collaborative Stage (CS)
- •Coding Collaborative Stage
- •Coding Collaborative Stage
- •CS Extension: Brain and
- •CS Extension: Brain and
- •CS Extension: Brain and
- •CS Extension: Brain and
- •CS Extension: Other CNS
- •CS Extension: Other CNS
- •CS Extension: Other CNS
- •CS Extension: Other Endocrine
- •CS Lymph Nodes
- •CS Metastasis at Diagnosis
- •CS Metastasis at Diagnosis
- •CS Site-specific Factor 1 (1)
- •CS Site-specific Factor 1 (2)
- •Possible Risk Factors
- •Possible Risk Factors
- •Genetic Syndromes
- •Diagnostic Tools – Physical Exam
- •Diagnostic Tools: Radiology
- •Diagnostic Tools: Laboratory
- •Diagnostic Tools
- •College of American Pathologist
- •Brain and Spinal Cord
- •Brain and Spinal Cord
- •Treatment (1)
- •Treatment (2)
- •Surgical Procedure of Primary
- •Site
- •Surgical Procedure of Primary
- •Surgical Procedure of Primary
- •Surgical Procedure of Primary
- •Surgical Procedure of Primary
- •Surgical Procedure of Primary
- •Surgical Margins of the Primary
- •Scope of Regional Lymph Node
- •Radiation Therapy (1)
- •Radiation Therapy (2)
- •Radiation Therapy (3)
- •Radiation Therapy (3)
- •Radiation Therapy (4)
- •Radiation Therapy (5)
- •Chemotherapy (1)
- •Chemotherapy (2)
- •Chemotherapy (3)
- •Hormone Therapy
- •Immunotherapy (1)
- •Immunotherapy (2)
- •Hematologic Transplant and
- •Technical Issues
- •Technical Issues
- •References
- •References
- •References
- •References
- •References
- •References
- •References
- •Acknowledgments (1)
- •Acknowledgments (2)
- •Acknowledgments (3)
- •Acknowledgments (4)
Childhood versus Adult
Tumors
CNS tumor histology and location are different in adult and children.
Tumor location and extent of spread affect treatment and prognosis.
Most common solid tumor in childhood.
51
Childhood Brain Tumors
Meduloblastomas are the most common CNS histology in children.
50% are infratentorial.
Common infratentorial tumors:
•Cerebellar astrocytomas
•Meduloblastomas
•Ependymomas
•Brain stem gliomas
•Atypical teratoid tumors
52
Cellular Classification
Childhood Brain Tumors (1)
Supratentorial tumors in children
• |
• |
Glioblastoma |
|
•Craniopharyngiomas |
|
|
|
Germ cell tumors |
multiforme |
|
|
• |
• |
Low-grade or anaplastic |
|
Diencephalic and |
|
||
hypothalamic gliomas |
• |
ependymomas |
|
• |
|
|
|
Low grade |
•Choroid plexus tumors |
||
astrocytomas |
|
Pineal parenchymal |
|
• |
tumors |
|
|
Mixed gliomas |
|
||
• |
• |
|
|
Anaplastic |
•Gangliogliomas |
|
|
astrocytomas |
|
Desmoplastic infantile |
|
• |
• |
gangliogliomas |
|
•Oligodendrogliomas |
|
||
•PNETs |
|
Dysembryoplastic |
53 |
Meningiomas |
neuroepithelial tumors |
|
Cellular Classification
Childhood Brain Tumors (2)
The histopathology of childhood spinal tumors is the same as for childhood brain tumors.
Primary spinal cord tumors comprise approximately 1% to 2% of all childhood CNS tumors.
54
Cellular Classification
Childhood CNS Tumors
Cause of childhood CNS tumors remains unknown.
American Academy of Pediatrics has outlined guidelines for pediatric cancer centers and their role in the treatment of pediatric cancer patients.
55
ICD-O-3 Coding Issues (1)
Some histologies may be difficult to determine if the primary site is intracranial or the skull (C41.0).
Non-malignant tumors of the skull are not reportable.
•Chondroma (M9220/0) must originate in a brain-related site to be reportable.
•Chordoma (M9370/3) and chondrosarcoma (M9220/3) are malignant.
Tumors in brain-related sites are analyzed separately from those in the skull.
56
ICD-O-3 Coding Issues (2)
Continue to assign histology code M9421/3 to pilocytic astrocytoma.
When the primary site for intracranial schwannoma (9560/0) is not documented in source documents, the site should be coded to cranial nerves NOS (C72.5).
57
Grade for CNS Tumors
Sixth digit of ICD-O-3 histology code
•Describes tumor differentiation or grade.
•Is not usually specified for CNS tumors.
•Is always assigned code 9 for non- malignant CNS tumors:
Not determined, not stated, or not applicable.
Per ICD-O-3, page 30, Rule G, paragraph 1 “Only malignant tumors are graded.”
• Not the same as WHO grade.
58
WHO Grade (1)
WHO grade coded in Collaborative Stage data field:
• Site-specific factor 1 for Brain.
Four-category tumor grading system
Grade I
Slow growingNon-malignant tumors
Patients have long-term survival.
59
WHO Grade (2)
Grade II
Relatively slow growing
Sometimes recur as higher grade tumorsMay be non-malignant or malignant .
Grade III
Malignant tumors
Often recur as higher grade tumors.
Grade IV
Highly malignant and aggressive.
60